Pressure BioSciences

Easton, United States Founded: 1978 • Age: 48 yrs
Biomolecular reactions are controlled via pressure cycling technology.
Annual revenue $2.0M Latest available
Total funding - 24 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About Pressure BioSciences

Pressure BioSciences is a company based in Easton (United States) founded in 1978. Pressure BioSciences has completed 4 acquisitions, including BaroFold, CannaWorx and CannaWorx. Pressure BioSciences offers products and services including BaroShear TM K45, Barocycler 2320EXT, and Barofold TM. Pressure BioSciences operates in a competitive market with competitors including Evosep, Ovizio, Curiox, inveox and AcouSort, among others.

  • Headquarter Easton, United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Pressure Biosciences, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.98 M (USD)
    14.36
    as on Dec 31, 2023
  • Net Profit
    -$29.31 M (USD)
    -82.34
    as on Dec 31, 2023
  • EBITDA
    -$9.39 M (USD)
    -101.3
    as on Dec 31, 2023
  • Latest Funding Round
    $10 M (USD), Post-IPO

    Mar 01, 2023

  • Investors
    NIH

    & 1 more

  • Employee Count
    Not available
  • Investments & Acquisitions
    BaroFold

    & 3 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Pressure BioSciences

Pressure BioSciences is a publicly listed company on the OTC with ticker symbol PBIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OTC · Ticker: PBIO · Sector: Health technology · USA

Products & Services of Pressure BioSciences

Pressure BioSciences offers a comprehensive portfolio of products and services, including BaroShear TM K45, Barocycler 2320EXT, and Barofold TM.

Product name locked
Category locked
Primary

Device for efficient preparation of high-quality water-soluble nanoemulsions.

Product name locked
Category locked
Locked

Compact bench-top tool for simultaneous high-pressure sample processing.

Product name locked
Category locked
Locked

High-pressure system for refolding proteins in life sciences research.

People of Pressure BioSciences

Headcount 10-50
Employee Profiles 7
Employee Profiles
People
Richard T. Schumacher
President, & CEO
People
Gary Smejkal
Senior Research Scientist
People
Ken Micciche
Director of Business Development
People
Alexander Lazarev
Chief Science Officer

Unlock access to complete

Funding Insights of Pressure BioSciences

Investors in Pressure BioSciences

Pressure BioSciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Premium access

Investor details for Pressure BioSciences

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Pressure BioSciences

Pressure BioSciences has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include BaroFold, CannaWorx and CannaWorx.

Investments
Premium access

Investment portfolio details for Pressure BioSciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
FDA-cleared cannabis products are provided for medical and wellness uses.
Locked Locked 2019 Locked
Brand of natural beauty and personal care products
Locked Locked 2018 Locked
Cannabis solutions are developed and provided by Cannaworx.
Locked Locked 2014 Locked
Premium access

Complete acquisition details for Pressure BioSciences

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Pressure BioSciences

Premium access

Detailed financials for Pressure BioSciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Pressure Biosciences Comparisons

Pressure BioSciences Primary company
Description
Biomolecular reactions are controlled via pressure cycling t...
Location
Easton, United States
Founded Year
1978
Annual Revenue
$1.98 M (USD)
Net Profit
-$29.31 M (USD)
EBITDA
-$9.39 M (USD)
Employees
Not available
Premium access

Peer comparison for Pressure BioSciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Pressure BioSciences

Pressure BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evosep, Ovizio, Curiox, inveox and AcouSort, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Solutions for clinical proteomics sample preparation are developed.
Locked Locked Locked
Imaging systems and AI software for microscopes are developed.
Locked Locked Locked
Wall-less plates and washers are developed for automated cell-based assays.
Locked Locked Locked
Automated solutions for biopsy sample preparation in laboratories are provided.
Locked Locked Locked
Microfluidic acoustofluidics technology for cell separation is developed.
Premium access

Detailed competitors of Pressure BioSciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Pressure Biosciences

Premium access

Complete news archive for Pressure BioSciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pressure BioSciences

Pressure BioSciences was founded in 1978 and raised its 1st funding round 28 years after it was founded.

Pressure BioSciences is headquartered in Easton, United States.

Annual revenue of Pressure BioSciences is $1.98M as on Dec 31, 2023.

Pressure BioSciences was founded in 1978 and is headquartered in Easton, United States. Operations focus on biotechnology, where a platform technology is employed to manage biomolecular interactions. Proprietary pressure cycling technology (PCT) applies cycles of hydrostatic pressure from ambient to ultra-high levels exceeding 35,000 psi. This approach supports applications in biomarker discovery, drug development, and forensics.

Pressure BioSciences's top competitors include Ovizio, Curiox and Evosep.

Pressure BioSciences offers BaroShear TM K45, Barocycler 2320EXT, and Barofold TM.

Yes, Pressure BioSciences is publicly traded on OTC under the ticker symbol PBIO.

Pressure BioSciences has made 4 acquisitions, including BaroFold, CannaWorx, and CannaWorx.

Pressure BioSciences has 2 investors. Key investors include NIH, and HHS.

The ticker symbol of Pressure BioSciences is PBIO on OTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available